BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

N/A
indicator

Nifty MidSmall Healthcare

1D
1M
3M
6M
1Y
5Y
empty graph

Nifty MidSmall Healthcare Performance

Day's Range

Low

₹48,185.00

High

₹48,764.15

52 Week Range

Low

₹40,352.90

High

₹48,764.15

Previous Close ₹48,102.20
Day's Range ₹48,185.00 - ₹48,764.15
Open ₹48,267.00
52 Week Range ₹40,352.90 - ₹48,764.15
Volume 4,67,85,783

Nifty MidSmall Healthcare Companies

Company Name LTP (₹) Change (₹) Sector
Lupin Ltd. 2287.40 Arrow 35.00 (1.55%) Healthcare
Abbott India Ltd. 27795.00 Arrow -130.00 (-0.47%) Healthcare
Glaxosmithkline Pharmaceuticals Ltd. 2389.40 Arrow -0.40 (-0.02%) Healthcare
Pfizer Ltd. 4785.40 Arrow -73.90 (-1.52%) Healthcare
JB Chemicals & Pharmaceuticals Ltd. 2171.60 Arrow 46.30 (2.18%) Healthcare
Ipca Laboratories Ltd. 1656.20 Arrow 9.90 (0.60%) Healthcare
Neuland Laboratories Ltd. 16790.00 Arrow 463.00 (2.84%) Healthcare
Aurobindo Pharma Ltd. 1512.80 Arrow 12.30 (0.82%) Healthcare
Natco Pharma Ltd. 1130.90 Arrow -34.70 (-2.98%) Healthcare
Poly Medicure Ltd. 1455.10 Arrow 2.90 (0.20%) Healthcare

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 23618.0 26373.20 22182.55
Nifty IT 29308.0 40301.40 27078.00
Nifty Next 50 68992.35 72037.60 59896.10
NIFTY50 USD Index 8479.65 10443.40 8132.40
Nifty Bank 53409.15 61764.85 49954.85
NIFTY Midcap 100 61022.0 62113.85 52032.85
Nifty 500 22521.75 24144.20 20385.65
Nifty Midcap 50 17413.75 17686.30 14804.55
Nifty 100 24531.7 26975.15 22720.45
Nifty FMCG 50883.35 58485.05 45334.15

Latest News

May
18
2026
EQUITY Posted on May 18th 2026

Glenmark Pharmaceuticals informs about media release

Glenmark Pharmaceuticals has informed that, Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch1 of Vancomycin Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial. Glenmark’s Vancomycin Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial is bioequivalent and therapeutically equivalent to the reference listed drug, Vancomycin Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial of Fresenius Kabi USA, LLC. The company has attached media release.
The above information is a part of company’s filings submitted to BSE.
Read More
May
16
2026
EQUITY Posted on May 16th 2026

Krishna Institute of Medical Sciences informs about investor presentation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has enclosed the Investor Presentation on audited (Standalone & Consolidated) financial results of the Company for the quarter and financial year ended 31st March 2026. The said presentation is being uploaded on the website of the Company i.e., https://www.kimshospitals.com/investors/Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015/Analysts Calls schedule, PPT & Transcripts/PPT's.
The above information is a part of company’s filings submitted to BSE.
Read More
May
16
2026
EQUITY Posted on May 16th 2026

Onesource Specialty Pharma informs about updates

Onesource Specialty Pharma has informed that the Government of Karnataka has accorded in-principle approval for the application submitted by the Company for Unit-II expansion project under the Karnataka Industrial Policy (KIP) 2025-30, towards incentives and concessions.
The above information is a part of company’s filings submitted to BSE.
Read More
May
16
2026
EQUITY Posted on May 16th 2026

Krishna Institute of Medical Sciences informs about newspaper publication

Pursuant to the provisions of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed that it enclosed a copy of the newspaper publication on the audited (Standalone and Consolidated) financial results of the company for the quarter and financial year ended 31st March 2026, published in Financial Express (English) and Navatelangana (Telugu). The said publication may also be accessed on the website of the company.

The above information is a part of company’s filings submitted to BSE.

Read More
May
16
2026
EQUITY Posted on May 16th 2026

Gland Pharma informs about newspaper advertisement

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Gland Pharma has informed that it enclosed copies of the newspaper advertisement pertaining to Audited Financial Results of the Company for the financial year ended March 31, 2026. The advertisements were published in English and Telugu newspapers.

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of NFTMIDSMLHEALTH index?

The previous close of NFTMIDSMLHEALTH index is ₹48622.6 as of 2026-05-19.

The total volume of NFTMIDSMLHEALTH index is 46785783.00 as of 2026-05-19.

The percentage change in value of NFTMIDSMLHEALTH index is 1.08% as of 2026-05-19.

The absolute increase in NFTMIDSMLHEALTH index value since the previous trading day is ₹520.4 as of 2026-05-19.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore